In the News

  • Pages

  • /
  • In the News

Silurian Pharmaceuticals, Inc. Receives a Development Program Award from Cystic Fibrosis Foundation

Silurian Pharmaceuticals, Inc. Receives a Development Program Award from Cystic Fibrosis Foundation

August 29, 2018

Silurian Pharmaceuticals, Inc, received an award from the Cystic Fibrosis Foundation (CFF) for the development of its drug BREVENAL for the treatment of defective mucociliary clearance (MCC) in CF patients.

[more...]